Phenomex Inc 's ability to collect accounts receivable sequentially worsen to 3.67, indicating more challenging environment then in the first quarter 2023, but still, it is a far cry from any concerns. Phenomex Inc 's Accounts Receivable average collection period in the Jun 30 2023 quarter, has increased to 99 days, from 92 days, in the Mar 31 2023 quarter.

If we take a look into Healthcare sector 514 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2023 from 2969 to 3334.

What is Receivable Turnover Ratio?
What is Phenomex Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CELL Receivables Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Receivable Change	4.05 %	41.75 %	-28.56 %	-18.04 %	-30.09 %
Y / Y Revenue Change	-26.67 %	-8.36 %	-23.05 %	-12.03 %	-0.52 %
Receivable Turnover Ratio (TTM)	3.67	3.96	4.47	4.32	4.23
CELL's Total Ranking	# 3334	# 2969	# 2607	# 2761	# 2764
Accounts Receivable average collection period days	99	92	82	85	86
Seq. Receivable Change	-42.77 %	35.53 %	-8.5 %	46.62 %	-22.04 %
Seq. Revenue Change	-24.16 %	3.78 %	-16.62 %	11.74 %	-5.23 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 28
Healthcare Sector	# 515
Overall Market	# 3334

Receivable Turnover Ratio Statistics
High	Average	Low
4.47	3.42	1.42
(Dec 31 2022)		(Mar 31 2021)

CELL Company Profile • Back to CELL Efficiency Comparisons • Compare CELL Receivables Turnover Ratio to its Competitors

Financial Statements
Phenomex Inc 's Accounts Receivable	$ 14 Millions	Visit CELL's Balance sheet
Phenomex Inc 's Sales TTM	$ 72 Millions	Visit CELL's Income Statement
Sources of CELL's Revenues		Visit CELL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CELL's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CELL's Growth Rates	CELL's Roa	CELL's Inventory Turnover Ratio	CELL's Dividend Comparisons
CELL's Profitability Ratios	CELL's Roi	CELL's Asset Turnover Ratio	CELL's Dividend Growth
CELL's Valuation Ratios	CELL's Roe	CELL's Financial Strength Ratios	CELL's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2023	Receivable at quarter ending Jun 30 2023
Neptune Wellness Solutions Inc	13.72	$ 46.971 Millions	$ 3.423 Millions
Corcept Therapeutics Inc	13.64	$ 428.153 Millions	$ 31.395 Millions
U S Physical Therapy Inc	13.45	$ 236.957 Millions	$ 17.621 Millions
Revance Therapeutics Inc	13.44	$ 186.401 Millions	$ 13.872 Millions
Lifeloc Technologies Inc	13.25	$ 8.586 Millions	$ 0.648 Millions
Talkspace Inc	13.11	$ 128.554 Millions	$ 9.803 Millions
Plus Therapeutics Inc	13.07	$ 2.584 Millions	$ 0.198 Millions
Exact Sciences Corporation	12.96	$ 2,297.345 Millions	$ 177.234 Millions
International Stem Cell Corporation	12.77	$ 8.060 Millions	$ 0.631 Millions
Travere Therapeutics Inc	12.69	$ 226.054 Millions	$ 17.813 Millions
Marizyme Inc	12.67	$ 0.485 Millions	$ 0.038 Millions
Catalyst Pharmaceuticals Inc	12.63	$ 302.949 Millions	$ 23.994 Millions
Icu Medical Inc	12.46	$ 2,292.847 Millions	$ 184.062 Millions
Strata Critical Medical Inc	12.44	$ 190.117 Millions	$ 15.284 Millions
Vbi Vaccines Inc	12.39	$ 1.815 Millions	$ 0.147 Millions
Eton Pharmaceuticals Inc	12.33	$ 28.703 Millions	$ 2.327 Millions
Scienture Holdings Inc	12.14	$ 9.443 Millions	$ 0.778 Millions
Zomedica Corp	12.04	$ 21.463 Millions	$ 1.783 Millions
Teladoc Health Inc	12.00	$ 2,530.761 Millions	$ 210.854 Millions
Intellia Therapeutics Inc	11.95	$ 53.039 Millions	$ 4.438 Millions
Rockwell Medical inc	11.93	$ 74.722 Millions	$ 6.265 Millions
Emmaus Life Sciences Inc	11.77	$ 28.381 Millions	$ 2.411 Millions
Precipio inc	11.74	$ 10.956 Millions	$ 0.933 Millions
Lipocine Inc	11.73	$ 0.541 Millions	$ 0.046 Millions
Amylyx Pharmaceuticals Inc	11.55	$ 191.874 Millions	$ 16.618 Millions
Integrated Biopharma Inc	11.50	$ 50.061 Millions	$ 4.353 Millions
Zymeworks Inc	11.49	$ 447.704 Millions	$ 38.966 Millions
Milestone Scientific Inc	11.41	$ 9.944 Millions	$ 0.872 Millions
Avita Medical Inc	11.31	$ 40.850 Millions	$ 3.612 Millions
Semler Scientific inc	11.28	$ 64.653 Millions	$ 5.733 Millions

Date modified: 2026-08-29T17:42:08+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.